ValiRx plc (LON:VAL – Get Free Report)’s stock price shot up 11.2% on Tuesday . The company traded as high as GBX 0.70 ($0.01) and last traded at GBX 0.70 ($0.01). 1,651,426 shares were traded during mid-day trading, a decline of 87% from the average session volume of 12,576,879 shares. The stock had previously closed at GBX 0.63 ($0.01).
ValiRx Trading Down 3.7 %
The firm’s 50-day simple moving average is GBX 0.73 and its 200 day simple moving average is GBX 1.42. The firm has a market cap of £2.47 million, a P/E ratio of -0.44 and a beta of 0.59. The company has a quick ratio of 1.27, a current ratio of 6.65 and a debt-to-equity ratio of 0.44.
About ValiRx
ValiRx accelerates the development of treatments in cancer and women’s health to improve patient lives. We provide the scientific, financial and commercial framework to enable the rapid translation of innovative science into clinical development.
See Also
- Five stocks we like better than ValiRx
- The 3 Best Fintech Stocks to Buy Now
- 3 Beauty Stocks Off to an Ugly Start—Can 1 Stage a Comeback?
- How to Use the MarketBeat Dividend Calculator
- Fastenal : Growth Trends, Challenges & Key Investment Insights
- Consumer Discretionary Stocks Explained
- 2 Auto Stocks to Let Go and 1 Worth Buying for the Long Haul
Receive News & Ratings for ValiRx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ValiRx and related companies with MarketBeat.com's FREE daily email newsletter.
